Health Press Bhutan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Bhutan.

Press releases published on September 9, 2026

11 hours ago

Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

11 hours ago

Monogram Health Publishes Inaugural Impact Report, Documenting Impressive Clinical and Financial Outcomes Resulting From Its In-Home Multispecialty Medical Group Care Model

Indeterminate GlobeNewswire

11 hours ago

Rezera Announces Ruvonoflast Met its Primary Inflammation Endpoint and Demonstrated Favorable Safety Profile in RESOLVE-1 Phase 2 Clinical Trial

Indeterminate GlobeNewswire

11 hours ago

ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026

Indeterminate GlobeNewswire

11 hours ago

Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

11 hours ago

Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates

Indeterminate GlobeNewswire

11 hours ago

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

11 hours ago

IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development

Indeterminate GlobeNewswire

11 hours ago

Callio Therapeutics Appoints Zachary Hornby as Chief Executive Officer

Indeterminate GlobeNewswire

11 hours ago

Jushi Holdings Inc. Announces Open-Market Share Purchases by Chief Executive Officer, Chairman and Founder Jim Cacioppo

Indeterminate GlobeNewswire

11 hours ago

NodThera Inc. Changes Name to Rezera Inc. and Announces Ruvonoflast Phase 3 Development Program

Indeterminate GlobeNewswire

11 hours ago

Quantum-Si Expands Proteus™ Roadshow with Additional U.S. and European Cities

Indeterminate GlobeNewswire

11 hours ago

Aktis Oncology to Present at Upcoming September Investor Conferences

Indeterminate GlobeNewswire

11 hours ago

Starton Therapeutics to Present at the 17th Annual World Bispecific Summit in Boston

Indeterminate GlobeNewswire

11 hours ago

INmune Bio to Present at the H.C. Wainwright Global Investment Conference

Indeterminate GlobeNewswire

11 hours ago

AEON Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of ABP-450 to BOTOX®

Indeterminate GlobeNewswire

11 hours ago

electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers

Indeterminate GlobeNewswire

11 hours ago

Humacyte Announces FDA Authorization Extending Symvess Shelf Life to 36 Months

Indeterminate GlobeNewswire

11 hours ago

Persephone Biosciences Celebrates First Birthday of Bloom and Thrive Synbiotics, with More Than 1.5 Million Doses Manufactured

Indeterminate GlobeNewswire

11 hours ago

MBX Biosciences to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire